Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 3/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.57 |
| ▸ | GSK3B | P49841 | 2/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.57 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.57 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.57 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.57 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 5/20 | 0.50 |
| ▸ | RAB9A | P51151 | 5/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.50 |
| ▸ | FEN1 | P39748 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9787087 | 0.83 | GSK3B (0.61) | HDAC3HDAC1HDAC2HDAC6GSK3B | |
| SCHEMBL10418143 | 0.81 | HDAC3 (0.62) | HDAC3HDAC1HDAC2HDAC6GSK3B | |
| SCHEMBL8427290 | 0.79 | TPMT (0.46) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL10418650 | 0.79 | HDAC1 (0.70) | HDAC3HDAC1HDAC2HDAC6GSK3B | |
| SCHEMBL7806272 | 0.79 | NPC1 (0.55) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL10876907 | 0.79 | HDAC3 (0.53) | HDAC3HDAC1HDAC2HDAC6GSK3B | |
| SCHEMBL6745410 | 0.79 | HDAC3 (0.67) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL6320924 | 0.78 | ALDH1A1 (0.61) | HDAC3HDAC1HDAC2HDAC6GSK3B | |
| SCHEMBL879474 | 0.78 | ALDH1A1 (0.61) | HDAC3HDAC1HDAC2HDAC6GSK3B | |
| SCHEMBL2549394 | 0.78 | ALDH1A1 (0.63) | HDAC3HDAC1HDAC2HDAC6GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023086801-A1 | HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE | VIGIL NEUROSCIENCE, INC. (US) | 2023-05-19 | — | — | WO | disclosed |
| US-8461184-B2 | Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonists | SOLVAY PHARMACEUTICALS B.V. (NL) | 2013-06-11 | — | — | US | disclosed |
| US-8309584-B2 | Sulfur containing pyrazole-heterocycle derivatives as cannabinoid CB1 receptor antagonists | GREEN CROSS CORPORATION (KR) | 2012-11-13 | — | — | US | disclosed |
| US-20110178140-A1 | SULFUR CONTAINING PYRAZOLE-HETEROCYCLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS | GREEN CROSS CORPORATION (KR) | 2011-07-21 | — | — | US | disclosed |
| US-20100292204-A1 | SULPHUR CONTAINING PYRAZOLE DERIVATIVES AS SELECTIVE CANNABINOID CB1 RECEPTOR ANTAGONISTS | SOLVAY PHARMACEUTICALS, B.V. | 2010-11-18 | — | — | US | disclosed |
| US-7786144-B2 | Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonists | SOLVAY PHARMACEUTICALS B.V. (NL) | 2010-08-31 | — | — | US | disclosed |
| WO-2010035915-A1 | SULFUR CONTAINING PYRAZOLE-HETEROCYCLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS | GREEN CROSS CORPORATION (KR) | 2010-04-01 | — | — | WO | disclosed |
| EP-2029548-A1 | SULPHUR CONTAINING PYRAZOLE DERIVATIVES AS SELECTIVE CANNABINOID CB1 RECEPTOR ANTAGONISTS | Solvay Pharmaceuticals B.V. (NL) | 2009-03-04 | — | — | EP | disclosed |
| WO-2007138050-A1 | SULPHUR CONTAINING PYRAZOLE DERIVATIVES AS SELECTIVE CANNABINOID CB1 RECEPTOR ANTAGONISTS | SOLVAY PHARMACEUTICALS B.V. (NL) | 2007-12-06 | — | — | WO | disclosed |
| US-20070281973-A1 | SULPHUR CONTAINING PYRAZOLE DERIVATIVES AS SELECTIVE CANNABINOID CB1 RECEPTOR ANTAGONISTS | ABBVIE B.V. (NL) | 2007-12-06 | — | — | US | disclosed |
| EP-1125931-A1 | Biocidal alkyl-substituted-(hetero)aryl-ketoxime-O-ethers and the production method thereof | Hunan Research Institute of Chemical Industry (CN) | 2001-08-22 | — | — | EP | disclosed |
| US-6013839-A | REACTING A 2,4-DIHALOACETOPHENONE WITH A THIOLATING AGENT UNDER ANHYDROUS CONDITIONS; EFFICIENCY; INTERMEDIATES OF HERBICIDES E.G., BENZAMIDE DERIVATIVES | RHONE-POULENC AGRICULTURE LIMITED (GB) | 2000-01-11 | — | — | US | disclosed |
| EP-0883605-A1 | PROCESS FOR PREPARING 2-(THIOSUBSTITUTED)-4-HALOACETOPHENONES | RHONE-POULENC AGRICULTURE LTD. (GB) | 1998-12-16 | — | — | EP | disclosed |
| US-5798311-A | INSECTICIDES | ROHM AND HAAS COMPANY (US) | 1998-08-25 | — | — | US | disclosed |
| WO-1997030026-A1 | PROCESS FOR PREPARING 2-(THIOSUBSTITUTED)-4-HALOACETOPHENONES | RHONE-POULENC AGRICULTURE LIMITED (GB) | 1997-08-21 | — | — | WO | disclosed |
| EP-0466408-A1 | N-aryl-3-aryl-4-substituted-4,5-dihydro-1H-pyrazole-1-carboxamides and processes for their production | ROHM AND HAAS COMPANY (US) | 1992-01-15 | — | — | EP | disclosed |
| US-4971979-A | Antiinflammatory agents | RHONE-POULENC SANTE (FR) | 1990-11-20 | — | — | US | disclosed |
| US-4886835-A | ANTIINFLAMMATORY AGENTS | RHONE-POULENC SANTE (FR) | 1989-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178140-A1 | SULFUR CONTAINING PYRAZOLE-HETEROCYCLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS | CNR1, CNR2, GPR119 | HDAC3 245/4885HDAC1 548/4885HDAC2 1186/4885 |
| US-20100292204-A1 | SULPHUR CONTAINING PYRAZOLE DERIVATIVES AS SELECTIVE CANNABINOID CB1 RECEPTOR ANTAGONISTS | CNR1, CNR2, CBR1 | HDAC3 997/4885HDAC1 1451/4885HDAC2 1527/4885 |
| US-20070281973-A1 | SULPHUR CONTAINING PYRAZOLE DERIVATIVES AS SELECTIVE CANNABINOID CB1 RECEPTOR ANTAGONISTS | CNR1, CNR2, CBR1 | HDAC3 997/4885HDAC1 1451/4885HDAC2 1527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.